Prem S. Shah
Known title: EVP and Co-President of RetailCIK: 0001900910
Associated companies
Transaction History
| CVS | ▼ Sell | Tax Withholding | 1,484 | $108K | 4/1/2026 | View on chart |
| CVS | ▲ Buy | Grant | 25,062 | $1.8M | 3/31/2026 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 247 | $20K | 1/1/2026 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 6,995 | $512K | 8/31/2025 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 1,308 | $89K | 4/1/2025 | View on chart |
| CVS | ▲ Buy | Grant | 26,478 | $1.8M | 4/1/2025 | View on chart |
| CVS | ▲ Buy | Option Exercise | 846 | $53K | 3/17/2025 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 2,653 | $211K | 4/1/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 5,239 | $417K | 4/1/2024 | View on chart |
| CVS | ▲ Buy | Grant | 15,082 | $0 | 4/1/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 261 | $20K | 2/26/2024 | View on chart |
| CVS | ▼ Sell | Open Market | 29,473 | $2.3M | 2/16/2024 | View on chart |
| CVS | ▲ Buy | Grant | 13,313 | $0 | 2/12/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 3,508 | $229K | 8/31/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 3,221 | $239K | 4/1/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 226 | $19K | 2/27/2023 | View on chart |
| CVS | ▲ Buy | Grant | 20,376 | $0 | 8/31/2022 | View on chart |
| CVS | ▲ Buy | Grant | 20,671 | $0 | 5/31/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 3,157 | $171K | 4/8/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 3,157 | $331K | 4/8/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 5,719 | $600K | 4/8/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 845 | $53K | 4/8/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 845 | $89K | 4/8/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 4,103 | $431K | 4/8/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 4,103 | $305K | 4/8/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 5,719 | $334K | 4/8/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 3,130 | $329K | 4/8/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 18,747 | $1.9M | 4/1/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 3,731 | $377K | 4/1/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 5,346 | $547K | 3/30/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 5,346 | $560K | 3/30/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 2,935 | $313K | 3/17/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 2,935 | $308K | 3/17/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 1,689 | $180K | 3/17/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 141 | $15K | 2/28/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 226 | $24K | 2/26/2022 | View on chart |
| CVS | ▲ Buy | Grant | 47,640 | $0 | 2/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.